In the next stage of this research involving clinical trials, the scientists intend to test the effectiveness of these reversible monoamine oxidase A inhibitors in the treatment of postpartum depression.
The next step is the conversion of the baseline hydroxylysine into structural compounds called allysines; this reaction takes place with help from the lysyl oxidase enzyme.